But if the contract states there are no competing customers, and talks about 4 different sites, I'd say most bases should have been covered.
Az then turning around, and using three of these sites exclusively for UK production (since it was 'first') kinda defeats that.
Then there is indeed a difference in contract law, where the UK is far more focused on the letter of the contract, while European law is more about 'what could have been done'.
In the middle of a pandemic there isn't much we can do against pharmaceuticals. In the mean while has Az delivered more than Moderna until now.
So, we should take what we can. Only thing we could blame the EC on is that we should not have based our strategy of vaccinating out on such an unreliable, inexperienced partner with a complicated biological process.
Looking back and keeping the Pfizer vaccin European would have been less naive, but we would have started these vaccins wars.
Will be interesting what the long term consequences are of having UK and US vaccinated two months sooner.
I don't think Europe will forget this.
But if the contract states there are no competing customers, and talks about 4 different sites, I'd say most bases should have been covered.
But does the AZ-EU Advance Purchase Agreement[1], which is the somewhat redacted document that was published, talk about 4 different sites? I haven't found anything about specific sites so far, nor any guarantee that there are no competing customers. Have I missed something?
In section 5.1, it does state that AZ shall use its BREs to manufacturer the Initial European Doses within the EU. Then in section 5.4, it states that AZ shall use its BREs to manufacture the Vaccine at manufacturing sites located within the EU, and that specifically for section 5.4 only, that includes the UK. If the exception proves the rule, those sections together appear to imply that AZ must try to manufacture those initial batches for the EU within the EU not including the UK, and then any subsequent manufacture can be done in either the EU or UK (and otherwise there are some additional provisions about other possibilities). Maybe a lawyer can comment on the choice of language there, but it seems awkwardly written to me.
It does not say there is no competing contract, it says no contract would prevent fulfilment of its contract. The EU contract stipulates that the delivery schedule is only an estimate, so another contract that was estimated to permit that delivery schedule would not conflict. It also seems to stipulate that the initial 300M doses will be manufactured within the EU, but this is incidental to this claim.
Then there is indeed a difference in contract law, where the UK is far more focused on the letter of the contract, while European law is more about 'what could have been done'.
In the middle of a pandemic there isn't much we can do against pharmaceuticals. In the mean while has Az delivered more than Moderna until now. So, we should take what we can. Only thing we could blame the EC on is that we should not have based our strategy of vaccinating out on such an unreliable, inexperienced partner with a complicated biological process. Looking back and keeping the Pfizer vaccin European would have been less naive, but we would have started these vaccins wars. Will be interesting what the long term consequences are of having UK and US vaccinated two months sooner. I don't think Europe will forget this.